ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

RP105 protects against ischemic and septic acute kidney injury via suppressing TLR4/NF-κB signaling pathways

Zhu, Jiefu; Zhang, Yafei; Shi, Lang; Xia, Yao; Zha, Hongchu; Li, Huimin; Song, Zhixia*武汉大学; 1
International Immunopharmacology2022-8DOI: 10.1016/j.intimp.2022.108904
7被引7阅读
引用收藏
分享

摘要

Acute kidney injury (AKI) is a critical and severe clinical disease caused by a variety of factors. Toll-like receptors (TLRs) play a crucial role in pathogenesis of AKI. Radioprotective 105 kDa protein (RP105) is a member of the TLR family, but the role of RP105 in AKI is unknown. In this study, we overexpressed RP105 in renal tissue and cultured proximal tubular cells in which we then induced ischemic and septic AKI. Renal structure injuries were examined by hematoxylin eosin staining, while renal function was assessed by measuring serum blood urea nitrogen (BUN) and creatinine (SCr) levels. The TUNEL assay was used to detect apoptosis induced changes in the expression of RP105, and nuclear factor.B (NF-kappa B) in renal tissue detected by Western blot. Inflammatory cytokines including iNOS, IL-1 ss, IL-6, and TNF-alpha were detected by quantitative real-time PCR. The inflammatory indicators, F4/80 and MPO, were identified by IHC staining. The results showed that expression of the TLR4/NF kappa B signaling pathway was enhanced in renal ischemia-reperfusion injury and septic renal injury, and that overexpression of RP105 in renal tissue alleviated ischemic and septic AKI. Moreover, RP105 gene delivery was associated with reduced renal inflammatory cells infiltration and inflammatory cytokines after AKI. RP105 overexpression also inhibited nuclear translocation of NF-.B after AKI in both in vitro and in vivo, and blunted the interaction between Myeloid Differentiation factor 2 (MD2) and TLR4. These results indicated that RP105 protected against renal ischemic and septic AKI injury by suppressing inflammatory responses mediated by TLR4 signaling pathways. This study suggests that the anti-inflammatory roles of RP105 have potential for preventing and treating renal ischemic and septic AKI.

学科与关键词

关键词
Ischemia reperfusion injurySepsisAcute kidney injuryRP105TLR4
相关
加载中…
  • Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway
    Li, Ying; Xiong, Yanying; Li, Huihui; Luo, Yan; Zhang, Ling; Zhang, Qin; Xiong, Weijian*; Tu, Haitao*Journal of Immunology Research, 2022, 2022: 6869730.
  • Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis
    Li, Chao; Ma, Qiu-ying; Liu, Xue-qi; Li, Hai -di; Yu, Ming-jun; Xie, Shuai-shuai; Ma, Wen-xian; Chen, Ying; Wang, Jia-nan; He, Ruo-bing; Bian, He-ge; He, Yuan; Gao, Li; Deng, Sheng-song; Zang, Hong-mei; Gong, Qian; Wen, Jia-gen; Liu, Ming-ming; Yang, Chen; Chen, Hai-yong; Li, Jun; Lan, Hui-yao; Jin, Juan*; Yao, Ri-sheng*; Meng, Xiao-ming*Molecular Therapy, 2023, 31(9): 2734-2754.被引 1
  • RIP3 impedes transcription factor EB to suppress autophagic degradation in septic acute kidney injury
    Li, Ruizhao; Zhao, Xingchen; Zhang, Shu; Dong, Wei; Zhang, Li; Chen, Yuanhan; Li, Zhilian; Yang, Huan; Huang, Ying; Xie, Zhiyong; Wang, Weidong; Li, Chunling; Ye, Zhiming; Dong, Zheng; Liang, Xinling*Cell Death & Disease, 2021, 12(6): 593.被引 18
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2022-08
卷期
第 109 卷
DOI
10.1016/j.intimp.2022.108904
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
foundation of health commission of Hubei Province [WJ2021M066]; Natural Science Foundation of Hubei Province [2021CFB379, 2021CFB101]

作者

  • Z

    Zhu, Jiefu (第一作者)

    wuhan univ

  • Z

    Zhang, Yafei

    1 · three gorges univ

查看全部 7 位作者收起作者
  • S

    Shi, Lang

    wuhan univ

  • X

    Xia, Yao

    1 · three gorges univ

  • Z

    Zha, Hongchu

    1 · three gorges univ

  • L

    Li, Huimin

    three gorges univ

  • S

    Song, Zhixia (通讯)

    1 · three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417